ANTINEOPLASTIC AGENTS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
IMATINIB MESYLATE: products 1 to 20 of 20.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Ach-Imatinib 100mg TabDIN 02490986 | General benefit | $5.2079per source unit | Requirements & sourcesBuild cost plan |
| Ach-Imatinib 400mg TabDIN 02490994 | General benefit | $20.8314per source unit | Requirements & sourcesBuild cost plan |
| Apo-Imatinib 100mg TabDIN 02355337 | General benefit | $5.2079per source unit | Requirements & sourcesBuild cost plan |
| Apo-Imatinib 400mg TabDIN 02355345 | General benefit | $20.8314per source unit | Requirements & sourcesBuild cost plan |
| Gleevec 100mg TabDIN 02253275 | General benefit | $5.2079per source unit | Requirements & sourcesBuild cost plan |
| Gleevec 400mg TabDIN 02253283 | General benefit | $20.8314per source unit | Requirements & sourcesBuild cost plan |
| Imatinib 100mg TabDIN 02504596 | General benefit | $5.2079per source unit | Requirements & sourcesBuild cost plan |
| Imatinib 100mg TabDIN 02521202 | General benefit | $5.2079per source unit | Requirements & sourcesBuild cost plan |
| Imatinib 400mg TabDIN 02504618 | General benefit | $20.8314per source unit | Requirements & sourcesBuild cost plan |
| Imatinib 400mg TabDIN 02521210 | General benefit | $20.8314per source unit | Requirements & sourcesBuild cost plan |
| Jamp Imatinib 100mg TabDIN 02495066 | General benefit | $5.2079per source unit | Requirements & sourcesBuild cost plan |
| Jamp Imatinib 400mg TabDIN 02495074 | General benefit | $20.8314per source unit | Requirements & sourcesBuild cost plan |
| Mint-Imatinib 100mg TabDIN 02492334 | General benefit | $5.2079per source unit | Requirements & sourcesBuild cost plan |
| Mint-Imatinib 400mg TabDIN 02492342 | General benefit | $20.8314per source unit | Requirements & sourcesBuild cost plan |
| Nat-Imatinib 100mg TabDIN 02397285 | General benefit | $5.2079per source unit | Requirements & sourcesBuild cost plan |
| Nat-Imatinib 400mg TabDIN 02397293 | General benefit | $20.8314per source unit | Requirements & sourcesBuild cost plan |
| PMS-Imatinib 100mg TabDIN 02431114 | General benefit | $5.2079per source unit | Requirements & sourcesBuild cost plan |
| PMS-Imatinib 400mg TabDIN 02431122 | General benefit | $20.8314per source unit | Requirements & sourcesBuild cost plan |
| Teva-Imatinib 100mg TabDIN 02399806 | General benefit | $5.2079per source unit | Requirements & sourcesBuild cost plan |
| Teva-Imatinib 400mg TabDIN 02399814 | General benefit | $20.8314per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
10:00 ANTINEOPLASTIC AGENTS.